SK, Car­lyle bol­ster blue­bird bio bid; Theri­ni Bio rais­es $39M

Plus, news about Al­lo­gene, Kyver­na, Ser­no­va, ADC Ther­a­peu­tics, Ace­lyrin, Alu­mis, Atara, La­va Ther­a­peu­tics and Re­pare Ther­a­peu­tics:

SK, Car­lyle of­fer more up­front cash to blue­bird bio …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER